39
Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Embed Size (px)

Citation preview

Page 1: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Malaria Pathogenesis and Clinical Presentation

Gail Stennies, MD, MPHMalaria Epidemiology Branch

May, 2002

Page 2: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Plasmodium species which infect humans

Plasmodium vivax (tertian)

Plasmodium ovale (tertian)

Plasmodium falciparum (tertian)

Plasmodium malariae (quartian)

Page 3: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Exo-erythrocytic (hepatic) cycle

Sporozoites

Mosquito Salivary Gland

Malaria Life CycleLife Cycle

Gametocytes

Oocyst

Erythrocytic Cycle

Zygote

Schizogony

Sporogony

Hypnozoites(for P. vivax and P. ovale)

Page 4: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Malaria Transmission Cycle

Parasite undergoes sexual reproduction in the mosquito

Some merozoites differentiate into male or female gametocyctes

Erythrocytic Cycle: Merozoites infect red blood cells to form schizonts

Dormant liver stages (hypnozoites) of P. vivax and P. ovale

Exo-erythrocytic (hepatic) Cycle: Sporozoites infect liver cells and develop into schizonts, which release merozoites into the blood

MOSQUITO HUMAN

Sporozoires injected into human host during blood meal

Parasites mature in mosquito midgut and migrate to salivary glands

Page 5: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Components of the Malaria Life Cycle

Mosquito Vector

Human Host

Sporogonic cycle

Infective Period

Mosquito bitesgametocytemic person

Mosquito bitesuninfected person

Prepatent Period

Incubation Period

Clinical Illness

Parasites visible

Recovery

Symptom onset

Page 6: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Exo-erythrocytic (tissue) phase

• Blood is infected with sporozoites about 30 minutes after the mosquito bite

• The sporozoites are eaten by macrophages or enter the liver cells where they multiply –

pre-erythrocytic schizogeny

• P. vivax and P. ovale sporozoites form parasites in the liver called hypnozoites

Page 7: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Exo-erythrocytic (tissue) phase

• P. malariae or P. falciparum sporozoites do not form hypnozites, develop directly into pre-erythrocytic schizonts in the liver

• Pre-erythrocytic schizogeny takes 6-16 days post infection

• Schizonts rupture, releasing merozoites which invade red blood cells (RBC) in liver

Page 8: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Relapsing malaria

• P. vivax and P. ovale hypnozoites remain dormant for months

• They develop and undergoe pre-erythrocytic sporogeny

• The schizonts rupture, releasing merozoites and produce clinical relapse

Page 9: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Exo-erythrocytic (hepatic) cycle

Sporozoites

Mosquito Salivary Gland

Malaria Life CycleLife Cycle

Gametocytes

Oocyst

Erythrocytic Cycle

Zygote

Schizogony

Sporogony

Hypnozoites(for P. vivax and P. ovale)

Page 10: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Exo-erythrocytic (tissue) phase

• P. vivax and P. ovale hypnozoites remain dormant for months

• They develop and undergoe pre-erythrocytic sporogeny

• The schizonts rupture, releasing merozoites and producing clinical relapse

Page 11: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Erythrocytic phase

• Pre-patent period – interval between date of infection and detection of parasites in peripheral blood

• Incubation period – time between infection and first appearance of clinical symptoms

• Merozoites from liver invade peripheral (RBC) and develop causing changes in the RBC

• There is variability in all 3 of these features depending on species of malaria

Page 12: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Erythrocytic phasestages of parasite in RBC

• Trophozoites are early stages with ring form the youngest

• Tropohozoite nucleus and cytoplasm divide forming a schizont

• Segmentation of schizont’s nucleus and cytoplasm forms merozoites

• Schizogeny complete when schizont ruptures, releasing merozoites into blood stream, causing fever

• These are asexual forms

Page 13: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Erythrocytic phasestages of parasite in RBC

• Merozoites invade other RBCs and schizongeny is repeated

• Parasite density increases until host’s immune response slows it down

• Merozoites may develop into gametocytes, the sexual forms of the parasite

Page 14: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Schizogenic periodicity and fever patterns

• Schizogenic periodicity is length of asexual erythrocytic phase– 48 hours in P.f., P.v., and P.o. (tertian)– 72 hours in P.m. (quartian)

• Initially may not see characteristic fever pattern if schizogeny not synchronous

• With synchrony, periods of fever or febrile paroxsyms assume a more definite 3 (tertian)- or 4 (quartian)- day pattern

Page 15: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Clinical presentation

• Early symptoms– Headache– Malaise– Fatigue– Nausea– Muscular pains– Slight diarrhea– Slight fever, usually not intermittent

• Could mistake for influenza or gastrointestinal infection

Page 16: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Clinical presentation

• Acute febrile illness, may have periodic febrile paroxysms every 48 – 72 hours with

• Afebrile asymptomatic intervals• Tendency to recrudesce or relapse over months to

years• Anemia, thrombocytopenia, jaundice,

hepatosplenomegaly, respiratory distress syndrome, renal dysfunction, hypoglycemia, mental status changes, tropical splenomegaly syndrome

Page 17: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Clinical presentation

• Early symptoms– Headache– Malaise– Fatigue– Nausea– Muscular pains– Slight diarrhea– Slight fever, usually not intermittent

• Could mistake for influenza or gastrointestinal infection

Page 18: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Clinical presentation

• Signs– Anemia– Thrombocytopenia– Jaundice– Hepatosplenomegaly– respiratory distress syndrome– renal dysfunction– Hypoglycemia– Mental status changes– Tropical splenomegaly syndrome

Page 19: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Types of Infections

• Recrudescence– exacerbation of persistent undetectable parasitemia, due to

survival of erythrocytic forms, no exo-erythrocytic cycle (P.f., P.m.)

• Relapse– reactivation of hypnozoites forms of parasite in liver, separate

from previous infection with same species (P.v. and P.o.)

• Recurrence or reinfection – exo-erythrocytic forms infect erythrocytes, separate from

previous infection (all species)

• Can not always differentiate recrudescence from reinfection

Page 20: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Clinical presentation• Varies in severity and course• Parasite factors

– Species and strain of parasite– Geographic origin of parasite – Size of inoculum of parasite

• Host factors– Age– Immune status– General health condition and nutritional status– Chemoprophylaxis or chemotherapy use

• Mode of transmission– Mosquito– Bloodborne, no hepatic phase (transplacental, needlestick, transfusion, organ

donation/transplant)

Page 21: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Malarial Paroxysm

• Can get prodrome 2-3 days before– Malaise, fever,fatigue, muscle pains, nausea, anorexia– Can mistake for influenza or gastrointestinal infection– Slight fever may worsen just prior to paroxysm

• Paroxysm– Cold stage - rigors– Hot stage – Max temp can reach 40-41o C,

splenomegaly easily palpable– Sweating stage – Lasts 8-12 hours, start between midnight and midday

Page 22: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Malarial Paroxysm

• Periodicity– Days 1 and 3 for P.v., P.o., (and P.f.) - tertian– Usually persistent fever or daily paroxyms for

P.f.– Days 1 and 4 for P.m. - quartian

Page 23: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Presentation of P.v.

• Lack classical paroxysm followed by asymptomatic period

• Headache,dizziness, muscle pain, malaise, anorexia, nausea, vague abdominal pain, vomiting

• Fever constant or remittent• Postural hypotension, jaundice, tender

hepatosplenomegaly

Page 24: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Common features of P.vivax infections

• Incubation period in non-immunes 12-17 days but can be 8-9 months or longer

• Some strains from temperate zones show longer incubation periods, 250-637 days

• First presentation of imported cases – 1 month – over 1 year post return from endemic area

• Typical prodromal and acute symptoms– Can be severe– However, acute mortality is very low

Page 25: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Common features of P.vivax infections

• Most people of West African descent are resistant to P.v.– Lack Duffy blood group antigens needed for

RBC invasion

• Mild – severe anemia, thrombocytopenia, mild jaundice, tender hepatosplenomegaly

• Splenic rupture carries high mortality– More common with P.v. than with P.f.

Page 26: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Common features of P.vivax infections

• Relapses– 60% untreated or inadequately treated will

relapse– Time from primary infection to relapse varies

by strain– Treat blood stages as well as give terminal

prophylaxis for hypnozoites

Page 27: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Common features of P. ovale infections

• Clinical picture similar to P.v. but• Spontaneous recovery more common• Fewer relapses• Anemia and splenic enlargement less severe • Lower risk of splenic rupture• Parasite often latent and easily suppressed by

more virulent species of Plasmodia• Mixed infection with P.o. usually in those exposed

in tropical Africa

Page 28: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Common features of P. malariae infections

• Clinical picture similar to P.v. but prodrome may be more severe

• Incubation period long – 18- 40 days• Anemia less pronounced than P.v.• Gross splenomegaly but risk of rupture less

common than in P.v.• No relapse – no hepatic phase or persisting

hepatic cycle

Page 29: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Common features of P. malariae infections

• Undetectable parasitemia may persist with symptomatic recrudescences– Frequent during first year– Then longer intervals up to 52 years

• Asymptomatic carriers may be detected at time of blood donation or in cases of congenital transmission

• Parasitemia rarely > 1%, all asexual stages can be present

• Can cause nephrotic syndrome, prognosis is poor

Page 30: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Features of P.falciparum cases• Lack classical paroxysm followed by asymptomatic period• Headache,dizziness, muscle pain, malaise, anorexia, nausea,

vague abdominal pain, vomiting• Fever constant or remittent• Postural hypotension, jaundice, tender hepatosplenomegaly• Can progress to severe malaria rapidly in non-immune

patients• Cerebral malaria can occur with P.f.• Parasites can sequester in tissues, not detected on peripheral

smear

Page 31: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Some characteristics of infection with four species of human Plasmodia

P.v. P.o. P.m. P.f.

Pre-erythroctic stage (days)

6-8 9 14-16 5.5-7

Pre-patent period (days)

11-13 10-14 15-16 9-10

Incubation period (days)

15 (12-17) or up to 6-12 months

17 (16-18) or longer

28 (18-40) or longer

12 (9-14)

Erythrocytic cycle (hours)

48 (about) 50 72 48

Page 32: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Some characteristics of infection with four species of human Plasmodia

P.v. P.o. P.m. P.f.

Paraitemia per μl

Average

Maximum

20,000

50,000

9,000

30,000

6,000

20,000

20,000-50,000

2,000,000

Primary attack*

Mild-severe

Mild Mild Severe in non-immunes

Febrile paroxysms (hours)

8-12 8-12 8-10 16-36 or longer

Page 33: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Some characteristics of infection with four species of human Plasmodia

P.v. P.o. P.m. P.f.

Invasion requirements

Duffy –ve blood group

? ? ?

Relapses ++ ++ - -

Recrude-scences

+ + - -

Page 34: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Some characteristics of infection with four species of human Plasmodia

P.v. P.o. P.m. P.f.

Period of recurrence **

Variable Variable Very long short

Duration of untreated infection (years)

1.5-5 Probably same as P.v.

3-50 1-2

*The severity of infection and the degree of parasitemia are greatly influenced by the immune response. Chemoprphylaxis May suppress an initial attack for weeks or months.** Patterns of infection and of relapses vary greatly in different strains.Bruce-Chwatt’ Essential Malariology, 3rd rev ed. 1993

Page 35: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Congenital malaria• Transplacental infection

– Can be all 4 species– Commonly P.v. and P.f. in endemic areas– P.m. infections in nonendemic areas due to long persistence of species

• Neonate can be diagnosed with parasitemia within 7 days of birth or longer if no other risk factors for malaria (mosquito exposure, blood transfusion)

• Fever, irritability, feeding problems, anemia, hepatosplenomegaly, and jaundice

• Be mindful of this problem even if mother has not been in malarious area for years before delivery

Page 36: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Immunity• Influenced by

– Genetics– Age– Health condition– Pregnancy status– Intensity of transmission in region– Length of exposure– Maintenance of exposure

Page 37: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Immunity

• Innate– Red cell polymorphisms associated with some

protection• Hemoglobin S sickle cell trait or disease• Hemoglobin C and hemoglobin E• Thalessemia – α and β • Glucose – 6 – phosphate dehydrogenase deficiency

(G6PD)– Red cell membrane changes

• Absence of certain Duffy coat antigens improves resistance to P.v.

Page 38: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Immunity

• Acquired– Transferred from mother to child

• 3-6 months protection• Then children have increased susceptibility

– Increased susceptibility during early childhood• Hyper- and holoendemic areas

– By age 5 attacks usually < frequent and severe– Can have > parasite densities with fewer symptoms

• Meso- or hypoendemic areas– Less transmission and repeated attacks– May acquire partial immunity and be at higher risk for

symptomatic disease as adults

Page 39: Malaria Pathogenesis and Clinical Presentation Gail Stennies, MD, MPH Malaria Epidemiology Branch May, 2002

Immunity

• Acquired– No complete immunity

• Can be parasitemic without clinical disease– Need long period of exposure for induction– May need continued exposure for maintenance– Immunity can be unstable

• Can wane as one spends time outside endemic area• Can change with movement to area with different

endemicity• Decreases during pregnancy, risk improves with

increasing gravidity